Unlock Global Insights – Save 20% on Market Reports with Code ONLINE20
How Is The Hospital-Acquired Infection Control Market Size Likely To Evolve From 2025 Through 2034?
The hospital-acquired infection control market has demonstrated sustained growth in recent years. It is projected to expand from $34.59 billion in 2024 to reach $35.75 billion by 2025, reflecting a compound annual growth rate (CAGR) of 3.4%. This market’s historical expansion is largely attributable to factors including increasing antibiotic resistance, heightened awareness, rigorous regulations, the worldwide spread of infectious diseases, and numerous patient safety initiatives.
The hospital-acquired infection control market is projected to experience substantial expansion over the upcoming years. This market is anticipated to reach a valuation of $44.06 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 5.4%. Key factors contributing to this anticipated growth include the emergence of multidrug-resistant pathogens, enhanced pandemic preparedness efforts, heightened surveillance and monitoring activities, the implementation of antimicrobial stewardship programs, and increased international collaboration. Significant trends expected during this period encompass the adoption of real-time location systems (RTLS), the integration of artificial intelligence (AI) for surveillance purposes, a move towards single-use and disposable devices, a greater focus on staff training and education, and the expanded use of advanced disinfection technologies.
Unlock Your Free Sample Report for Exclusive Market Data:
https://www.thebusinessresearchcompany.com/sample.aspx?id=7694&type=smp
What Are The Key Drivers Of Growth In The Hospital-Acquired Infection Control Market?
An anticipated rise in COVID-19 cases is predicted to drive the expansion of the hospital-acquired infection control market in the future. COVID-19 is defined as a viral illness stemming from the SARS-CoV-2 virus. The COVID-19 pandemic has led to heightened demand for hospital-acquired infection control products and services, emphasizing personal hygiene and the manufacturing of medical supplies for infection control. For example, the World Health Organization, a specialized agency of the United Nations located in Switzerland, reported that global COVID-19 cases had reached 581.6 million by 8th August 2022. Consequently, the increase in COVID-19 cases is fueling the growth of the hospital-acquired infection control market.
What Are The Primary Types Of Segments Analyzed In The Hospital-Acquired Infection Control Market?
The hospital-acquired infection controlmarket covered in this report is segmented –
1) By Product: Sterilizers; Disinfectors; Endoscope Reprocessors; Microbial Testing Instruments; Consumables; Disinfectants; Infection Prevention And Surveillance Software; Other Products
2) By Technology: Phenotypic Methods; Genotypic Methods
3) By Diseases: Hospital Acquired Pneumonia; Bloodstream Infections; Surgical Site Infections; Gastrointestinal Infections; Urinary Tract Infection; Other Diseases
4) By Application: Disease Testing; Drug-Resistance Testing
5) By End User: Hospitals; ICUs; Ambulatory Surgical; Diagnostic Centers; Nursing Homes; Maternity Centers; Other End Users
Subsegments:
1) By Sterilizers: Steam Sterilizers; Ethylene Oxide Sterilizers; Hydrogen Peroxide Sterilizers
2) By Disinfectors: Washer Disinfectors; Automated Disinfectors
3) By Endoscope Reprocessors: High-Level Disinfection Reprocessors; Automated Endoscope Reprocessors
4) By Microbial Testing Instruments: Culture Systems; Rapid Microbial Testing Systems
5) By Consumables: Sterilization Wraps; Filters; Personal Protective Equipment (PPE)
6) By Disinfectants: Alcohol-based Disinfectants; Chlorine-based Disinfectants; Quaternary Ammonium Compounds
7) By Infection Prevention And Surveillance Software: Surveillance Software Solutions; Data Management Software
8) By Other Products: Cleaning Equipment; Air Purification Systems
Which Trends Are Impacting The Hospital-Acquired Infection Control Market?
Key players in the hospital-acquired infection control market are prioritizing the development of new technological solutions, including AI systems, to assist in the early detection of sepsis. This focus aims to improve patient outcomes by enabling quicker diagnosis and treatment. Such AI systems are advanced technological tools that employ artificial intelligence and machine learning algorithms to identify early indications of sepsis in patients. For instance, in April 2024, Prenosis Inc., a US-based medical clinic, obtained FDA marketing authorization for its Sepsis ImmunoScore. This represents the first AI-driven system designed to predict sepsis, a critical condition potentially leading to severe complications. The innovative tool enhances early detection through real-time data analysis, empowering healthcare professionals to intervene more rapidly and effectively. The integration of AI is intended to support medical staff in their decision-making processes rather than replace them, ultimately contributing to better patient outcomes and reduced healthcare costs.
Who Are The Core Companies Influencing The Hospital-Acquired Infection Control Market Landscape?
Major companies operating in the hospital-acquired infection control market include Johnson and Johnson, P&G Professional, Honeywell International Inc., MMM Group, 3M Company, Becton Dickinson and Company, Reckitt Benckiser Group plc., Ecolab Inc, Olympus Corporation, Miele Group, Biomerieux SA, Getinge AB, Halyard Health Inc., Ansell Limited, Sotera Health LLC, Contec Inc., Cantel Medical Corp., Belimed AG, Nanosonics Limited, Advanced Sterilization Products Services Inc, Steelco S.P.A, Schülke & Mayr GmbH, Metrex Research LLC, Tristel Solutions Ltd., Whiteley Corporation, PDI Inc., Steris Healthcare PVT Ltd, Matachana Group, Pal International Ltd., Xttrium Laboratories Inc., Zep Inc.
Download The Full Report For Exclusive Market Findings:
What Are The Regional Market Dynamics Impacting The Hospital-Acquired Infection Control Industry?
North America was the largest region in the hospital-acquired infection control market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the hospital-acquired infection control market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Version Of The Hospital-Acquired Infection Control Market Report:
https://www.thebusinessresearchcompany.com/customise?id=7694&type=smp
Browse Through More Reports Similar to the Global Hospital-Acquired Infection Control Market 2025, By The Business Research Company
Advanced Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/advanced-analytics-global-market-report
Procurement Analytics Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/procurement-analytics-global-market-report
Healthcare Predictive Analytics Global Market Report 2025
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model